StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Galleri

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Jun 08, 2021 11:39am

106 Views

Post# 33347835

RE:RE:RE:RE:RE:RE:RE:RE:Galleri

Investortel, Lifton, Atkinson of Clarus, the Medical Journal publication and others have touted its virtues, however I can't understand how Grail gets its fanfair at a time when SZ had already beaten them to the punch with superior testing. Given Grails ongoing efforts to improve specificity percentages of their tests, SZ would seem to be a natural partner. All head scratching.........

Mermer2328 wrote:
when will someone other the Mr Tripp talk about Aristotle and how great it is?. it seems to be the best kept secret for way too long

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property